CalciMedica, Inc. Stock-Based Compensation
CalciMedica, Inc. (CALC) reported Stock-Based Compensation of $1.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-11
- CalciMedica, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $540.00K, a 54.04% decline year-over-year.
- CalciMedica, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $561.00K, a 2.19% increase year-over-year.
- CalciMedica, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $622.00K, a 1.58% decline year-over-year.
- CalciMedica, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $625.00K, a 19.97% decline year-over-year.
- CalciMedica, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $2.97M, a 28.45% increase from fiscal 2024.
- CalciMedica, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $2.31M, a 80.79% decline from fiscal 2023.
- CalciMedica, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $12.04M, a 566.24% increase from fiscal 2022.
- CalciMedica, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $1.81M, a 66.38% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $540.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.10M 10-Q · filed 2026-08-11 | $1.72M derived: sum of 3 quarters · filed 2026-08-11 | $2.35M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $561.00K 10-Q · filed 2026-05-12 | $1.18M derived: sum of 2 quarters · filed 2026-05-12 | $1.81M derived: sum of 3 quarters · filed 2026-05-12 | $2.98M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $622.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.25M derived: sum of 2 quarters · filed 2026-03-03 | $2.42M derived: sum of 3 quarters · filed 2026-08-11 | $2.97M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | $625.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.80M derived: sum of 2 quarters · filed 2026-08-11 | $2.35M 10-Q · filed 2025-11-12 | $2.98M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.72M 10-Q · filed 2026-08-11 | $2.36M derived: sum of 3 quarters · filed 2026-08-11 | $3.14M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $549.00K 10-Q · filed 2026-05-12 | $1.18M derived: sum of 2 quarters · filed 2026-05-12 | $1.96M derived: sum of 3 quarters · filed 2026-05-12 | $2.45M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $632.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.41M derived: sum of 2 quarters · filed 2026-03-03 | $1.90M derived: sum of 3 quarters · filed 2026-03-03 | $2.31M 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | $781.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.27M derived: sum of 2 quarters · filed 2025-11-12 | $1.68M 10-Q · filed 2025-11-12 | $1.65M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $486.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $900.00K 10-Q · filed 2025-08-12 | $868.00K derived: sum of 3 quarters · filed 2025-08-12 | $1.35M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $414.00K 10-Q · filed 2025-05-14 | $382.00K derived: sum of 2 quarters · filed 2025-05-14 | $864.00K derived: sum of 3 quarters · filed 2025-05-14 | $1.33M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $450.00K derived: sum of 2 quarters · filed 2025-03-27 | $913.00K derived: sum of 3 quarters · filed 2025-03-27 | $12.04M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $482.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $945.00K derived: sum of 2 quarters · filed 2024-11-13 | $12.07M 10-Q · filed 2024-11-13 | $12.82M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $463.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $11.59M 10-Q · filed 2024-08-12 | $12.34M derived: sum of 3 quarters · filed 2024-08-12 | $12.74M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $11.13M 10-Q · filed 2024-05-13 | $11.88M derived: sum of 2 quarters · filed 2024-05-13 | $12.28M derived: sum of 3 quarters · filed 2024-05-13 | $12.60M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $752.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.15M derived: sum of 2 quarters · filed 2024-03-28 | $1.47M derived: sum of 3 quarters · filed 2024-03-28 | $1.81M 10-K · filed 2024-03-28 | $6.71M 10-K · filed 2023-03-09 | |||
| 2022-09-30 | $399.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $720.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.05M 10-Q · filed 2023-11-09 | $4.97M 10-Q · filed 2022-11-10 | $2.56M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $656.00K 10-Q · filed 2023-08-11 | $3.29M 10-Q · filed 2022-08-12 | $2.16M derived: sum of 3 quarters · filed 2023-08-11 | $3.59M derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | $335.00K 10-Q · filed 2023-05-12 | $1.54M 10-Q · filed 2022-05-12 | $1.84M derived: sum of 2 quarters · filed 2023-05-12 | $3.27M derived: sum of 3 quarters · filed 2023-05-12 | $4.58M derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.93M derived: sum of 2 quarters · filed 2023-03-09 | $4.25M derived: sum of 3 quarters · filed 2023-03-09 | $5.38M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.74M derived: sum of 2 quarters · filed 2022-11-10 | $3.87M 10-Q · filed 2022-11-10 | $4.66M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.44M 10-Q · filed 2022-08-12 | $3.23M derived: sum of 3 quarters · filed 2022-08-12 | $3.79M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $1.13M 10-Q · filed 2022-05-12 | $1.92M derived: sum of 2 quarters · filed 2022-05-12 | $2.48M derived: sum of 3 quarters · filed 2022-05-12 | $2.69M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $787.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.35M derived: sum of 2 quarters · filed 2022-03-11 | $1.56M derived: sum of 3 quarters · filed 2022-03-11 | $1.79M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $561.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $775.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.00M 10-Q · filed 2021-11-12 | $1.19M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $440.00K 10-Q · filed 2021-08-12 | $630.00K derived: sum of 3 quarters · filed 2021-08-12 | |||||
| 2020-03-31 | $226.00K 10-Q · filed 2021-05-14 | $416.00K derived: sum of 2 quarters · filed 2021-05-14 | ||||||
| 2019-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $738.00K 10-K · filed 2021-03-05 | ||||||
| 2019-09-30 | $548.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |